Monday 9 November 2026 Export IMRX’s income statement to Excel — free account

Immuneering Corporation

IMRX

Healthcare Biotechnology

Immuneering Corporation’s revenue for fiscal 2022 (year ended December 2022) was $317,000.00.

EPS: +1.61%
Free cash flow: −40.2%

Quarter to September 2026, against a year earlier

Insider buying

3.68 0.31 +9.20%

Follow IMRX

Alert me

Market cap: $238.3M
P/E: n/m
Fwd P/E: n/m
Dividend yield: —
F-score: 3/9
ROIC: −198.4%
Net debt / EBITDA: 2.9×
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	—	—	—	—
EV/Sales Full definition →		—	—	—	—
EV/FCF Full definition →		—	—	—	—
Quick Ratio Full definition →		17.16	31.50	18.47	13.47
Current Ratio Full definition →		17.50	32.45	19.47	13.97
Net Debt/EBITDA Full definition →		12.58	10.07	7.73	5.60
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.85	1.37	0.96	0.69
Capex/Depreciation Full definition →		(7.33)	0.36	0.07	0.09
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Intangible Assets out of Total Assets Full definition →		0.03	0.03	0.03	0.04
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Free Cash Flow Yield Full definition →		—	—	—	—
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.22)	(0.29)	(0.26)	(0.26)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.23)	(0.29)	(0.26)	(0.26)
Cash per Share Full definition →		3.93	2.42	2.32	2.25
Shareholders Equity per Share Full definition →		4.96	3.19	2.95	2.61
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		4.96	3.19	2.95	2.61
Free Cash Flow Full definition →		(9.96)	(18.51)	(16.53)	(16.80)
Working Capital Full definition →		166.17	156.43	149.87	139.92
Capital Expenditures Full definition →		(0.12)	(0.08)	(0.03)	(0.02)
Net Current Asset Value Full definition →		162.75	153.12	146.67	136.83
EV/EBIT Full definition →		—	—	—	—
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Payables Full definition →		1.75	1.38	2.89	2.18
Average Assets Full definition →		142.35	132.75	121.06	211.81
Average Common Equity Full definition →		129.94	124.18	109.84	198.33

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly